Magelia® treatment of low input samples (5 - 85 ng) enabled characterization of clinically relevant pathogens to the single nucleotide resolution:
• Blind identification of all Salmonella serotypes for Magelia® treated samples vs. 5/8 samples for manual treatment underline a higher success rate (relevant for regulated environments).
• Optimal cleanup and negligible adapter-dimer formation made possible thanks to the Magelia® patented magnetic tweezer technology.
This Poster was presented at SLAS Europe 2021 virtual conference where Inorevia participated in the Innovation AveNEW Program, on June 22nd – 25th 2021.
Check out the Poster here
